Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-07248144 |
Trade Name | |
Synonyms | PF07248144|PF 07248144 |
Drug Descriptions |
PF-07248144 selectively inhibits KAT6, a histone acetyltransferase regulating gene expression, which may lead to tumor growth inhibition (J Clin Oncol 41, 2023 (suppl 16; abstr 1054)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178474 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + Palbociclib + PF-07248144 | Fulvestrant PF-07248144 Palbociclib | 0 | 1 |
Fulvestrant + PF-07248144 | Fulvestrant PF-07248144 | 0 | 1 |
Letrozole + Palbociclib + PF-07248144 | Letrozole PF-07248144 Palbociclib | 0 | 1 |
PF-07248144 | PF-07248144 | 0 | 1 |